Remove 2027 Remove Food and Drug Administration Remove Networking
article thumbnail

Amgen opens its most advanced manufacturing facility to date

European Pharmaceutical Review

“As part of Amgen’s global biomanufacturing network, Amgen Ohio will play an important role in helping us address serious disease around the world with our innovative biomedicines.” ” Amgen Ohio is nearly 300,000 ft 2 in size and will employ 400 full-time staff. .”

article thumbnail

Amgen commits $8m to clinical trial diversity programme

European Pharmaceutical Review

The additional support from Amgen is set to reach more than 300 diverse and community-oriented clinical investigators by 2027. Currently close to 80 percent of participants in clinical research trials are white, according to the Food and Drug Administration (FDA).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

OpSens Announces FDA Clearance for the SavvyWire™ for Use in Transcatheter Aortic Valve Replacement (TAVR) Procedures

Legacy MEDSearch

Food & Drug Administration (“FDA”) for the SavvyWire (“SavvyWire”), its new guidewire for transcatheter aortic valve replacement procedures, or TAVR. The global TAVR market is currently estimated at over 200,000 procedures and is expected to reach 400,000 in 2027. OpSens Inc. , About OpSens Inc.

FDA 52
article thumbnail

Article Reviews the Evolution of Arthroscopy from its Invention in 1912 to the Dawn of the Wireless ArthroFree™ Era

Legacy MEDSearch

BN by 2027. Developed by Cleveland-based Lazurite Holdings LLC, ArthroFree recently became the first wireless camera for arthroscopy and general endoscopy to receive market clearance from the Food and Drug Administration. This system has helped propel the arthroscopic market to an expected US $16.3